Taiwan FDA registration 797ec4a7ebab2ff12be5c743a7bf7b6b
LZI Benzodiazepine EIA Kit
TW: 靈芝苯二氮酵素免疫試劑
Taiwan·Risk Class 2·MD·LIN-ZHI INTERNATIONAL, INC·Registered Oct 31, 2018 – Oct 31, 2023ExpiredRegistration details
- Analysis ID
- 797ec4a7ebab2ff12be5c743a7bf7b6b
- License Form
- Ministry of Health Medical Device Import No. 031767
- Customs Code
- DHA05603176700
Company information
- Manufacturer
- LIN-ZHI INTERNATIONAL, INC
- Manufacturer Country
- United States
- Authorized Representative
- TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.
Product details
- Intended Use
- This product is used for the qualitative and semi-quantitative determination of benzodiazepine content in human urine, with a threshold of 200ng/mL or 300ng/mL.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A3170 Benzene (para)dinitrogen test system
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Oct 31, 2018
- Expiry Date
- Oct 31, 2023
About this record
Access comprehensive regulatory information for LZI Benzodiazepine EIA Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 797ec4a7ebab2ff12be5c743a7bf7b6b and manufactured by LIN-ZHI INTERNATIONAL, INC. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices